Search

everythinglearnresearchcommunity

for

Search:↓

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

Epidermal growth factor helps hair recover after chemotherapy.

Minoxidil may work for hair loss by reducing androgen sensitivity and altering hormone-related enzymes.

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

"Antiaging capilar" aims to restore youthful hair appearance by addressing age-related changes.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.

Antiandrogens can help treat female pattern hair loss.

Activating mitophagy may help manage a key immune response involved in the hair loss condition alopecia areata.

New treatments for chronic central serous chorioretinopathy show promise in preventing permanent vision loss.

ASLNC168501 may help restore hair growth in androgenetic alopecia by improving hair follicle stem cell function.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Overactive sonic hedgehog signaling worsens uterine scarring by reducing cell recycling.

Controlling inflammation can help heal diabetic foot ulcers.

PRP treatment may stimulate hair growth by promoting blood vessel formation, increasing growth factors, and preventing cell death.

Cancer can hijack the body's cell repair system to promote tumor growth, and targeting this process may improve cancer treatments.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

The combination of azelaic acid, minoxidil, and caffeine significantly increased the survival of skin flaps by affecting certain body channels and nitric oxide levels.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

Activating certain hair follicle cells could prevent hair loss from cancer treatments.

The apelinergic system might protect the heart from damage caused by doxorubicin.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Alkaloids show promise in treating cholangiocarcinoma by effectively targeting cancer cells.

There is no strong evidence that chemopreventive agents effectively prevent prostate cancer.

Minoxidil is an effective and safe treatment for common hair loss when applied to the skin, but more research is needed for optimal use.

mTOR may link different pathways in hair follicle tumor formation.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.